1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
A Biomarker Panel Increases the Diagnostic Performance for Epithelial Ovarian Cancer Type I and II in Young Women
(
- Contribution to journal › Article
- 2010
-
Mark
Neutralization of uPA with a Monoclonal Antibody Reduces Plasmin Formation and Delays Skin Wound Healing in tPA-Deficient Mice
(
- Contribution to journal › Article
-
Mark
Neutralisation of uPA with a monoclonal antibody reduces plasmin formation and delays skin wound healing in tPA-deficient mice.
(
- Contribution to journal › Article
- 2009
-
Mark
Estradiol attenuates EGF-induced rapid uPAR mobilization and cell migration via the G-protein-coupled receptor 30 in ovarian cancer cells.
(
- Contribution to journal › Article
- 2008
-
Mark
Cleaved forms of the urokinase plasminogen activator receptor in plasma have diagnostic potential and predict postoperative survival in patients with ovarian cancer.
(
- Contribution to journal › Article
-
Mark
Antibody-mediated targeting of the urokinase-type plasminogen activator proteolytic function neutralizes fibrinolysis in vivo.
(
- Contribution to journal › Article
- 2007
-
Mark
Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice: inhibitory effects on receptor-mediated uPA activity in vitro and in vivo
(
- Contribution to journal › Article
- 2006
-
Mark
EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor.
(
- Contribution to journal › Article
- 1989
-
Mark
The reaction of monoclonal antibodies with hordeins from five different Hordeum species.
(
- Contribution to journal › Article